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CASE REPORT

RESOLUTION OF GESTATIONAL GIGANTOMASTIA WITH
TERMINATION OF PREGNANCY
Syed Sarmad Bukhari, Haris Manan*, Mah Muneer Khan*, Syed Shahmeer Raza**
Department of Neurosurgery, Aga Khan University Hospital, Karachi, *Department of Surgery, Khyber Teaching Hospital, Peshawar,
**
Department of Surgery, Hayatabad Medical Complex, Hayatabad-Peshawar-Pakistan

Less than 100 cases of gestational gigantomastia have been described in literature. The aetiology
and risk factors are not well-established. Various treatments have been used with some consensus.
We present the case of a 47-year-old female who presented to us with bilateral gigantomastia in
her 16th week of gestation. She had massively enlarged breasts which were very painful. Relevant
laboratory investigations were normal. An incisional biopsy done prior to, and two trucut samples
at presentation to us, showed normal breast tissue proliferation. In the absence of adequate pain
control, it was decided to electively terminate the pregnancy and give a trial of tamoxifen. She
made a rapid recovery following termination without requiring the use of tamoxifen
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INTRODUCTION
Breast enlargement is a natural phenomenon that
occurs during puberty and pregnancy due to interplay
of hormones like oestrogen, progesterone, growth
hormone, prolactin and adrenal steroids. Any
disturbance in this balance can potentially lead to
Gestational Gigantomastia (gravidic gigantomastia,
mammary hyperplasia of pregnancy) or virginal
gigantomastia (if it occurs at puberty).1 According to
one criterion, gigantomastia can be defined as excess
in Breast weight that exceeds 3 % of body weight.2
Excess weight of Breast can lead to muscular
discomfort and ulceration due to stretching of skin.3
Breasts are of vital importance to the health of baby
especially in a developing country. There are only
100 cases so far reported in literature. A case study in
2011 led the doctors to believe Gigantomastia as one
of the possible causes of Mondor's syndrome and by
treating Gigantomastia at an early stage could
potentially prevent development of Mondor's
syndrome.4

CASE PRESENTATION
A 47-year-old female patient presented to the surgical
clinic with massively enlarged breasts for the past 2
months. She was 4 months pregnant at the time of
presentation. Both breasts had started enlarging
insidiously without any precipitating cause and were
exquisitely painful. Dimensions are given in table-1.
On examination, the skin overlying the
breasts was erythematous and painful to touch. The
nipple was normal in appearance and there was no
discharge. Skin was intact without any ulceration,
except for a scar on the right indicating the previous
biopsy site (Figure-1). Palpation of the breasts did not
reveal any distinct masses but a diffuse enlargement
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was appreciated. There was no axillary
lymphadenopathy. She denied any weight loss.
Physical examination was otherwise unremarkable.
Her medical and surgical history was unremarkable.
She had 8 children and never had any complications
in any of those pregnancies.
Standard prenatal labs; CBC with
differential; serum chemistry panel; liver function
tests; serum calcium and albumin levels; hormone
profile: oestrogen, progesterone, and prolactin were
all within normal range.
Prior to presentation she had an incisional
biopsy done at a different centre. There was a strong
suspicion of inflammatory breast cancer hence
several Trucut biopsies were taken and sent for
histopathology. The other differential considered was
lymphoma and tuberculosis of the breast. Results
from the earlier biopsy and trucut specimen showed
the tissue contained chronic inflammatory cells with
no evidence of breast neoplasm. Considering the
presentation of the patient it was considered prudent
to have the Trucut repeated from different sites. This
biopsy confirmed the histopathology to be the same
as the previous sample.
The diagnosis of gestational gigantomastia
was then considered. The patient was counselled
regarding her disease and she decided to terminate
the pregnancy before commencing tamoxifen. A
week following elective therapeutic abortion, her
condition rapidly improved. The breasts returned to
the pre-gestation size and her pain resolved. No
further intervention was done and the patient was not
asked to come for follow up since she lived in a
remote area of the country. However, inquiry about
her status was made over the telephone.
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Table-1: Breast dimensions of patient with
gestational gigantomastia at 16 weeks of pregnancy
Breast dimensions
Breast circumference
Breast length from base to nipple
Breast length from underarm to the tip of nipple

Right Left
46 cm 55 cm
30 cm 33 cm
47 cm 50 cm

Figure-1: Photograph showing the patient’s
breasts at presentation. Peau d'orange appearance
of the skin. Incision site of the incisional biopsy
can be seen on the right breast.

DISCUSSION
The occurrence of gigantomastia during pregnancy
and puberty has given support to the theory that
hormones such as oestrogen and prolactin can be
implicated in the pathogenesis. This also explains the
response to bromocriptine. Increased risk in
multiparous women is poorly understood.5 Some
authors have suggested that increased receptor
sensitivity in the presence of normal hormone levels
may be one explanation. Several cases have been
described in association with autoimmune diseases.
The major challenge in treating this case
was pain control in the presence of a live foetus.
Paracetamol was tried in the maximum possible dose
without much benefit while NSAIDs and tramadol
were withheld to prevent possible foetal
complications. It was difficult to ambulate the patient
and it was uncomfortable for her to lie down in any
position. The early gestational period coupled with
the severe pain demanded a more rapid solution. A
discussion with the patient and her husband ensued
and they decided that they would terminate the
pregnancy and the patient would be started on
tamoxifen.
It is recommended to have an elective
delivery (by induction of labour if baby is at the age
of viability) if the condition is complicated by
haemorrhage and necrosis of the breast, but in our
case the severe pain was the deciding factor.
Following elective termination of the pregnancy and
bilateral tubal ligation, the patient’s condition rapidly
improved on the second day. It was decided to

withhold tamoxifen. The patient’s breasts eventually
reduced in size considerably and she was not
followed up because of financial constraints.
It is interesting to note that removal of the
foetus and the placenta led to rapid resolution. We
believe that besides other hormones, progesterone
and human placental lactogen may have a yet
unidentified trophic role in these cases. On the other
hand, since some cases of gigantomastia have been
reported in the presence of autoimmune disease, we
do not know whether autoimmune disease could have
triggered the gigantomastia in this case. However,
since the patient's condition resolved on termination
of pregnancy, and she did not have any clinical
features suggesting autoimmune disease, this is less
likely.
It is recommended to follow the preliminary
protocol described by Rezai S et al in diagnosing and
treating these patients.6 This protocol includes the
following steps:
1 - Immediate workup for a patient presenting with
unilateral or bilateral gigantomastia includes
a- standard prenatal labs;
b- CBC with differential;
c- serum chemistry panel;
d- liver function tests;
e- serum calcium and albumin levels;
f- hormone profile: oestrogen, progesterone,
and prolactin.
2 - Send the following tests for anti-dsDNA, ANA,
RF, anti-Smith, CCP, antithyroglobulin, and antiTPO, in addition to ESR and CRP, to investigate
possible concomitant autoimmune disorders.
3 - To evaluate malignancy, perform a breast biopsy.
Any finding suspicious of malignancy should be
followed up with an MRI of the head and CT scan of
the thorax, abdomen, and pelvis to detect areas of
metastasis.
4 - Surgical intervention is not recommended in
uncomplicated cases of gestational gigantomastia due
to potential foetal compromise.
5 - Delivery via caesarean section or induction of
labour is recommended for pregnancies complicated
by breast necrosis, maternal sepsis, or haemorrhage.
6 - Trial of postpartum bromocriptine (2.5 mg twice
daily) with cessation of breastfeeding is
recommended to possibly reduce breast size before
surgical intervention. If bromocriptine is used during
pregnancy, serial foetal growth monitoring is
recommended.
7 - Final surgical intervention with bilateral total
mastectomy instead of reduction mammoplasty or
simple mastectomy is recommended, especially in
women desiring future pregnancy. There is an
increased rate of recurrence in patients who
underwent simple mastectomy or reduction
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mammoplasty. Total bilateral mastectomy is the
preferred surgical option.

2.

CONCLUSION

3.

Very few cases of gestational gigantomastia have
been described in literature. It is important to
understand the presentation and complete the full
work up to avoid mistaking it for malignant
conditions. Most cases of gigantomastia resolve
spontaneously in the postpartum period, as was the
case with our patient.
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